Alzheimer’s patients are often drowsy during the day, but it might not be because of poor sleep at night. Instead, a clinical trial that monitored patients’ sleep and then studied their brains after death discovered an entirely different reason for such sleepiness — they suffer a loss of neurons that help keep a person awake.…  read on >  read on >

The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progression in about a quarter of patients who were battling advanced colon cancer.…  read on >  read on >

Urinary tract infections are common and usually simple to treat. But for people who become sick enough to land in the hospital with one, an experimental antibiotic may soon offer a new treatment option — taken by mouth instead of delivered by IV. In a clinical trial, researchers found that the pill, called tebipenem HBr,…  read on >  read on >

(HealthDay News) –The nursing home industry is awash in ineffective care and staffing shortages, claims a new report that calls for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Experts from the National Academies of Sciences, Engineering, and Medicine minced no words in in their 605-page report, released Wednesday.…  read on >  read on >

COVID-19 increases people’s risk of dangerous blood clots and bleeding for months after infection, researchers say. The new findings suggest that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding. “Our findings arguably support [treatment] to avoid thrombotic events, especially for high-risk patients, and strengthen the importance of vaccination against…  read on >  read on >